
Tuberculosis
Research Projects
Tuberculosis (TB) is a leading cause of death among adults globally. In sub-Saharan Africa this is exacerbated by the HIV pandemic, but TB remains a leading cause of death globally, even in the absence of HIV, as it is first an foremost a disease of poverty. Unlike other important infectious disease priorities, TB is unique in that active infection is not readily confirmable through a simple blood test. Microbiological diagnosis requires a sputum specimen, and so you can only confirm TB disease in patients who are symptomatic. Our research at the University Teaching Hospital, has demonstrated culture confirmed TB in up to 10% of ‘non-TB suspects’ who could produce sputum (1). Our 2015 autopsy study showed that despite good awareness of the risk TB within the hospital, there are still many undiagnosed cases at post-mortem. In particular 17% of TB cases were undiagnosed and untreated multiple-drug resistant TB (MDR-TB)(2).
In children TB is grossly under-diagnosed, so much so that epidemiological global burden of disease studies do not even mention ‘TB’ or ‘Tuberculosis’ (3, 4). In stark contrast, autopsy studies undertaken by us and other groups in sub-Saharan Africa, have shown that up to 10% of deaths among hospital admissions are due to undiagnosed and untreated TB (5-7).
At HerpeZ we are trying to address these diagnostic failures through promoting broader screening of both adult and child admissions to the hospital and developing and evaluating new diagnostic tools or strategies. We have recently initiated a study to define the burden of TB in neonates born to mothers with a history of TB infection and we are developing capacity for analysis of TB cultures or fresh clinical specimens by next generation sequencing. We are also interested in nosocomial TB as a threat to both patients and staff working at busy poorly resourced hospitals across the region.
1. Bates, M., et al. 2012. Evaluation of the burden of unsuspected pulmonary tuberculosis and co-morbidity with non-communicable diseases in sputum producing adult inpatients. PLoS One 7:e40774.
2. Bates, M., et al. 2015. Burden of tuberculosis at post mortem in inpatients at a tertiary referral centre in sub-Saharan Africa: a prospective descriptive autopsy study. The Lancet infectious diseases 15:544-551.
3. Liu, L., et al. 2012. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379:2151-2161.
4. Liu, L., et al. 2015. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 385:430-440.
5. Bates, M., et al. 2013. Deaths due to respiratory tract infections in Africa: a review of autopsy studies. Curr Opin Pulm Med 19:229-237.
6. Bates, M., et al. 2016. Burden of respiratory tract infections at post mortem in Zambian children. BMC medicine 14:99.
7. Chintu, C., et al. 2002. Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet 360:985-990.
Up and coming TB conferences
TB Publications
- Achieving
sustainable development goals for HIV/AIDS in the Republic of the Congo -
Progress, obstacles and challenges in HIV/AIDS health services. Ghoma
Linguissi LS, Lucaccioni V, Bates M, Zumla A, Ntoumi F. Int J
Infect Dis. 2018 Dec;77:107-112.
- Tuberculosis:
advances and challenges in development of new diagnostics and biomarkers. Walzl G, McNerney R, du Plessis N, Bates M, McHugh TD, Chegou NN, Zumla A. Lancet Infect Dis. 2018 Jul;18(7):e199-e210.
- Taking
forward the Stop TB Partnership and World Health Organization Joint Theme for
World TB Day March 24th 2018 - "Wanted: Leaders for a TB-Free World. You
can make history. End TB". Tiberi S, Petersen E, Maeurer M, Ntoumi F, Yeboa-Manu D,
Mwaba P, Vilaplana C, Dar O, Bates M,
Corrah T, Rao M, Kapata N, Azhar EI, Memish ZA, Mfinanga S, Aseffa A, Ippolito
G, Migliori GB, Zumla A.
Int J Infect Dis. 2018
Mar;68:122-124.
- Outcomes of
multidrug-resistant tuberculosis in Zambia: a cohort analysis. Kapata N, Grobusch
MP, Chongwe G, Chanda-Kapata P, Ngosa W, Tembo M, Musonda S, Katemangwe P, Bates M, Mwaba P, Zumla A, Cobelens F. Infection.
2017 Aug 4.
- Enhancing
preparedness for tackling new epidemic threats. Zumla A, Ippolito G, McCloskey B, Bates M, Ansumana R, Heymann D, Kock R, Ntoumi F. Lancet Respir Med. 2017 Aug;5(8):606-608.
- Health systems in
the Republic of Congo: challenges and opportunities for implementing
tuberculosis and HIV collaborative service, research, and training activities. Linguissi LS, Gwom LC, Nkenfou CN, Bates M, Petersen E, Zumla A, Ntoumi F. Int J
Infect Dis. 2017 Mar;56:62-67.
- Performance of
the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed,
paraffin-embedded tissues. Polepole P, Kabwe M, Kasonde M, Tembo J, Shibemba A, O'Grady J, Kapata N, Zumla A, Bates M. Int J Mycobacteriol. 2017 Jan-Mar;6(1):87-93.
- The global
dynamics of diabetes and tuberculosis: the impact of migration and policy
implications. Girardi E,
Sañé Schepisi M, Goletti D, Bates
M, Mwaba P, Yeboah-Manu D, Ntoumi F, Palmieri F, Maeurer M, Zumla A, Ippolito G. Int J Infect Dis.
2017 Mar;56:45-53.
- Application of
highly portable MinION nanopore sequencing technology for the monitoring of
nosocomial tuberculosis infection. Bates M, Polepole P, Kapata N, Loose M, O'Grady
J. Int J Mycobacteriol. 2016 Dec;5
Suppl 1:S24.
- Learning from epidemiological, clinical and immunological studies on Mycobacterium africanum for improving current understanding of host-pathogen interactions, and for the development and evaluation of diagnostics, host-directed therapies and vaccines for Tuberculosis. Zumla A, Otchere ID, Mensah GI, Asante-Poku A, Gehre F, Maeurer M, Bates M, Mwaba P, Ntoumi F, Yeboah-Manu D. Int J Infect Dis. 2016 Dec 12.
- Burden of respiratory tract infections at post mortem in Zambian children. Bates M, Shibemba A, Mudenda V, Chimoga C, Tembo J, Kabwe M, Chilufya M, Hoelscher M, Maeurer M, Sinyangwe S, Mwaba P, Kapata N, Zumla A. BMC Med. 2016 Jul 1;14(1):99.
- Taking forward the World TB Day 2016 theme 'Unite to End Tuberculosis' for the WHO Africa Region. Ntoumi F, Kaleebu P, Macete E, Mfinanga S, Chakaya J, Yeboah-Manu D, Bates M, Mwaba P, Maeurer M, Petersen E, Zumla A. Int J Infect Dis. 2016 Mar 8.
- Tuberculosis and Mass Gatherings-opportunities for defining burden, transmission risk, and optimal surveillance, prevention and control measures at the annual Hajj pilgrimage. Zumla A, Saeed AB, Alotaibi B, Yezli S, Dar O, Bieh K, Bates M, Tayeb T, Mwaba P, Shafi S, McCloskey B, Petersen E, Azhar EI.Int J Infect Dis. 2016 Feb 9.
- The development, evaluation and performance of molecular diagnostics for detection of Mycobacterium tuberculosis. Bates M, Zumla A. Expert Rev Mol Diagn. 2016 Jan 6.
- Rapid infectious diseases diagnostics using Smartphones. Bates M, Zumla A. Annals of Translational Medicine. 2015 Sep;3(15):215.
- Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines. Schito M, Migliori GB, Fletcher HA, McNerney R, Centis R, D'Ambrosio L, Bates M, Kibiki G, Kapata N, Corrah T, Bomanji J, Vilaplana C, Johnson D, Mwaba P, Maeurer M, Zumla A.Clin Infect Dis. 2015 Oct 15;61Suppl 3:S102-18.
- Host-Directed Therapies for tackling Multi-Drug Resistant TB - learning from the Pasteur-Bechamp debates. Zumla A, Maeurer M; Host-Directed Therapies Network (HDT-NET) Consortium.Clin Infect Dis. 2015 Jul 28.
- Towards host-directed therapies for tuberculosis. Zumla A, Chakaya J, Hoelscher M, Ntoumi F, Rustomjee R, Vilaplana C, Yeboah-Manu D, Rasolof V, Munderi P, Singh N, Aklillu E, Padayatchi N, Macete E, Kapata N, Mulenga M, Kibiki G, Mfinanga S, Nyirenda T, Maboko L, Garcia-Basteiro A, Rakotosamimanana N, Bates M, Mwaba P, Reither K, Gagneux S, Edwards S, Mfinanga E, Abdulla S, Cardona PJ, Russell JB, Gant V, Noursadeghi M, Elkington P, Bonnet M, Menendez C, Dieye TN, Diarra B, Maiga A, Aseffa A, Parida S, Wejse C, Petersen E, Kaleebu P, Oliver M, Craig G, Corrah T, Tientcheu L, Antonio M, Rao M, McHugh TD, Sheikh A, Ippolito G, Ramjee G, Kaufmann SH, Churchyard G, Steyn A, Grobusch M, Sanne I, Martinson N, Madansein R, Wilkinson RJ, Mayosi B, Schito M, Wallis RS, Maeurer M. Nat Rev Drug Discov. 2015 Jul 17.
- Performance of urine lipoarabinomannan assays for paediatric tuberculosis in Tanzania. Kroidl I, Clowes P, Reither K, Mtafya B, Rojas-Ponce G, Ntinginya EN, Kalomo M, Minja LT, Kowuor D, Saathoff E, Kroidl A, Heinrich N, Maboko L, Bates M, O'Grady J, Zumla A, Hoelscher M, Rachow A. Eur Respir J. 2015 Jun 25.
- Why healthcare workers are sick of TB. von Delft A, Dramowski A, Khosa C, Kotze K, Lederer P, Mosidi T, Peters J.A, Smith J, van der Westhuizen H, von Delft D, Willems B, Bates M, Craig G, Maeurer M, Marais B, Mwaba P, Nunes E, Nyirenda T, Oliver M, Zumla A. Int J Infect Dis, 2015 Mar;32:147-51 IF1.9
- Perspectives on tuberculosis in pregnancy. Bates M, Ahmed Y, Kapata N, Maeurer M, Mwaba P, Zumla A. Int J Infect Dis, 2015 Mar 32:124-7
- Frequency of Mycobacterium tuberculosis-specific CD8+ T-cells in the course of anti-tuberculosis treatment. Axelsson-Robertson R, Rao M, Loxton AG, Walzl G, Bates M, Zumla A, Maeurer M. Int J Infect Dis. 2015 Mar;32:23-9.
- Tuberculosis treatment and management-an update on treatment regimens, trials, new drugs, and adjunct therapies. Zumla A, Chakaya J, Centis R, D'Ambrosio L, Mwaba P, Bates M, Kapata N, Nyirenda T, Chanda D, Mfinanga S, Hoelscher M, Maeurer M, Migliori GB. Lancet Respir Med. 2015 Mar;3(3):220-34.
- Burden of tuberculosis at post mortem in inpatients at a tertiary referral centre in sub-Saharan Africa: a prospective descriptive autopsy study. Bates M, Mudenda V, Shibemba A, Kaluwaji J, Tembo J, Kabwe M, Chimoga C, Chilukutu L, Chilufya M, Kapata N, Hoelscher M, Maeurer M, Mwaba P, Zumla A.Lancet Infect Dis. 2015 Mar 9
- The neglected global burden of tuberculosis in pregnancy. Zumla A, Bates M, Mwaba P. Lancet Glob Health. 2014 Dec;2(12);
- Pregnancy and infection. Zumla A, Bates M, Maeurer M. N Engl J Med. 2014 Sep 11;
- Rapid diagnostics urgently needed for killer infections. Zumla A, Gant V, Bates M, Mwaba P, Maeurer M, Memish ZA. Lancet Respir Med. 2013 Jun;1(4):284-5.
- TB and HIV in the Central African region: current knowledge and knowledge gaps. Janssen S, Huson MA, Bélard S, Stolp S, Kapata N, Bates M, van Vugt M, Grobusch MP. Infection. 2013 Dec 6.
- Multidrug-resistant TB in Zambia: review of national data from 2000 to 2011. Kapata N, Chanda-Kapata P, Bates M, Mwaba P, Cobelens F, Grobusch MP, Zumla A.Trop Med Int Health. 2013 Sep 11.
- Use of the Xpert(®) MTB/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynaecology inpatient wards at the University Teaching Hospital, Lusaka, Zambia. Bates M, Ahmed Y, Chilukutu L, Tembo J, Cheelo B, Sinyangwe S, Kapata N, Maeurer M, O'Grady J, Mwaba P, Zumla A. Trop Med Int Health. 2013 Sep;18(9):1134-40.
- Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Marais BJ, Lönnroth K, Lawn SD, Migliori GB, Mwaba P, Glaziou P, Bates M, Colagiuri R, Zijenah L, Swaminathan S, Memish ZA, Pletschette M, Hoelscher M, Abubakar I, Hasan R, Zafar A, Pantaleo G, Craig G, Kim P, Maeurer M, Schito M, Zumla A.Lancet Infect Dis. 2013 May;13(5):436-48.
- Drug-resistant tuberculosis: time for visionary political leadership. Abubakar I, Zignol M, Falzon D, Raviglione M, Ditiu L, Masham S, Adetifa I, Ford N, Cox H, Lawn SD, Marais BJ, McHugh TD, Mwaba P, Bates M, Lipman M, Zijenah L, Logan S, McNerney R, Zumla A, Sarda K, Nahid P, Hoelscher M, Pletschette M, Memish ZA, Kim P, Hafner R, Cole S, Migliori GB, Maeurer M, Schito M, Zumla A.Lancet Infect Dis. 2013 Jun;13(6):529-39.
- Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lawn SD, Mwaba P, Bates M, Piatek A, Alexander H, Marais BJ, Cuevas LE, McHugh TD, Zijenah L, Kapata N, Abubakar I, McNerney R, Hoelscher M, Memish ZA, Migliori GB, Kim P, Maeurer M, Schito M, Zumla A.Lancet Infect Dis. 2013 Apr;13(4):349-61.
- Deaths due to respiratory tract infections in Africa: a review of autopsy studies. Bates M, Mudenda V, Mwaba P, Zumla A.Curr Opin Pulm Med. 2013 May;19(3):229-37.
- Trends in childhood tuberculosis in Zambia: a situation analysis. Kapata N, Chanda-Kapata P, O'Grady J, Bates M, Mwaba P, Janssen S, Marais B, Cobelens F, Grobusch M, Zumla A. J Trop Pediatr. 2013 Apr;59(2):134-9.
- Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study. Bates M, O'Grady J, Maeurer M, Tembo J, Chilukutu L, Chabala C, Kasonde R, Mulota P, Mzyece J, Chomba M, Mukonda L, Mumba M, Kapata N, Rachow A, Clowes P, Hoelscher M, Mwaba P, Zumla A. Lancet Infect Dis. 2013 Jan;13(1):36-42.
- Evaluation of the burden of unsuspected pulmonary tuberculosis and co-morbidity with non-communicable diseases in sputum producing adult inpatients. Bates M, O'Grady J, Mwaba P, Chilukutu L, Mzyece J, Cheelo B, Chilufya M, Mukonda L, Mumba M, Tembo J, Chomba M, Kapata N, Rachow A, Clowes P, Maeurer M, Hoelscher M, Zumla A.PLoS One. 2012;7(7):e40774.
- Leprosy trends in Zambia 1991-2009. Kapata N, Chanda-Kapata P, Grobusch MP, O'Grady J, Bates M, Mwaba P, Zumla A.Trop Med Int Health. 2012 Oct;17(10):1289-93.
- Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic. O'Grady J, Bates M, Chilukutu L, Mzyece J, Cheelo B, Chilufya M, Mukonda L, Mumba M, Tembo J, Chomba M, Kapata N, Maeurer M, Rachow A, Clowes P, Hoelscher M, Mwaba P, Zumla A. Clin Infect Dis. 2012 Nov;55(9):1171-8.
- SeekTB, a two-stage multiplex real-time-PCR-based method for differentiation of the Mycobacterium tuberculosis complex. Reddington K, Zumla A, Bates M, van Soolingen D, Niemann S, Barry T, O'Grady J. J Clin Microbiol. 2012 Jul;50(7):2203-6.
- Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. McNerney R, Maeurer M, Abubakar I, Marais B, McHugh TD, Ford N, Weyer K, Lawn S, Grobusch MP, Memish Z, Squire SB, Pantaleo G, Chakaya J, Casenghi M, Migliori GB, Mwaba P, Zijenah L, Hoelscher M, Cox H, Swaminathan S, Kim PS, Schito M, Harari A, Bates M, Schwank S, O'Grady J, Pletschette M, Ditui L, Atun R, Zumla A. J Infect Dis. 2012 May 15;205 Suppl 2:S147-58.
- Scale-up of TB and HIV programme collaborative activities in Zambia - a 10-year review. Kapata N, Chanda-Kapata P, Grobusch MP, O'Grady J, Schwank S, Bates M, Jansenn S, Mwinga A, Cobelens F, Mwaba P, Zumla A.Trop Med Int Health. 2012 Jun;17(6):760-6.
- Tuberculosis and tuberculosis/HIV/AIDS-associated mortality in Africa: the urgent need to expand and invest in routine and research autopsies. Mudenda V, Lucas S, Shibemba A, O'Grady J, Bates M, Kapata N, Schwank S, Mwaba P, Atun R, Hoelscher M, Maeurer M, Zumla A.J Infect Dis. 2012 May 15;205 Suppl 2:S340-6.
- Tuberculosis in prisons: anatomy of global neglect. O'Grady J, Maeurer M, Atun R, Abubakar I, Mwaba P, Bates M, Kapata N, Ferrara G, Hoelscher M, Zumla A. Eur Respir J. 2011 Oct;38(4):752-4.
- Trends of Zambia's tuberculosis burden over the past two decades. Kapata N, Chanda-Kapata P, O'Grady J, Schwank S, Bates M, Mukonka V, Zumla A, Mwaba P.Trop Med Int Health. 2011 Nov;16(11):1404-9.
- Tuberculosis in prisons in sub-Saharan Africa--a potential time bomb. O'Grady J, Mwaba P, Bates M, Kapata N, Zumla A.S Afr Med J. 2011 Feb;101(2):107-8.
- Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosis. Mwaba P, McNerney R, Grobusch MP, O'Grady J, Bates M, Kapata N, Maeurer M, Zumla A.Trop Med Int Health. 2011 Jul;16(7):819-27.
- New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis.O'Grady J, Maeurer M, Mwaba P, Kapata N, Bates M, Hoelscher M, Zumla A. Curr Opin Pulm Med. 2011 May;17(3):134-41.
- Viewpoint: Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection. Zumla A, Atun R, Maeurer M, Mwaba P, Ma Z, O'Grady J, Bates M, Dheda K, Hoelscher M, Grange J.Trop Med Int Health. 2011 Jan;16(1):79-83.
- Tuberculosis in prisons in sub-Saharan Africa--the need for improved health services, surveillance and control. O'Grady J, Hoelscher M, Atun R, Bates M, Mwaba P, Kapata N, Ferrara G, Maeurer M, Zumla A. Tuberculosis (Edinb). 2011 Mar;91(2):173-8.
- Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa. Migliori GB, Dheda K, Centis R, Mwaba P, Bates M, O'Grady J, Hoelscher M, Zumla A.Trop Med Int Health. 2010 Sep;15(9):1052-66.
Book Chapters
- Tuberculosis co-morbidity with communicable and non-communicable diseases. Bates M, Marais B, Zumla A.Perspectives on Tuberculosis, Kaufmann, Rubin and Zumla-Cold Spring Harbour, ISBN 978-1-621820-73-4
Useful Links
Check out this amazing and moving testimony from TB Proof founders, Darlene and Arne von Delft, about their experience of nosocomial TB infection. We MUST take better care of our healthcare workers!!
Follow this link to find out about the great work TB Proof are doing to raise awareness of the risks of TB transmission in hospitals, and to tackle stigma